| Year |
Citation |
Score |
| 2023 |
Zhou G, Zhang W, Wen H, Su Q, Hao Z, Liu J, Gao Y, Zhang H, Ge B, Tong C, He X, Wang X. Esculetin improves murine mastitis induced by streptococcus isolated from bovine mammary glands by inhibiting NF-κB and MAPK signaling pathways. Microbial Pathogenesis. 185: 106393. PMID 37852550 DOI: 10.1016/j.micpath.2023.106393 |
0.301 |
|
| 2023 |
Liu J, Zhang Q, Wang J, Wang C, Lan T, Wang T, Wang B. Knockdown of BAP31 Downregulates Galectin-3 to Inhibit the Wnt/β-Catenin Signaling Pathway to Modulate 5-FU Chemosensitivity and Cancer Stemness in Colorectal Cancer. International Journal of Molecular Sciences. 24. PMID 37762705 DOI: 10.3390/ijms241814402 |
0.302 |
|
| 2023 |
Wu Z, Qu B, Yuan M, Liu J, Zhou C, Sun M, Guo Z, Zhang Y, Song Y, Wang Z. CRIP1 Reshapes the Gastric Cancer Microenvironment to Facilitate Development of Lymphatic Metastasis. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2303246. PMID 37409440 DOI: 10.1002/advs.202303246 |
0.301 |
|
| 2022 |
Liu J, Jing W, Wang T, Hu Z, Lu H. Functional metabolomics revealed the dual-activation of cAMP-AMP axis is a novel therapeutic target of pancreatic cancer. Pharmacological Research. 106554. PMID 36379357 DOI: 10.1016/j.phrs.2022.106554 |
0.312 |
|
| 2022 |
Roussel MF, Jonchere B, Williams J, Zindy F, Liu J, Robinson S, Farmer DM, Min J, Yang L, Stripay JL, Wang Y, Freeman BB, Yu J, Shelat AA, Rankovic Z. Combination of ribociclib with BET-bromodomain and PI3K/mTOR inhibitors for medulloblastoma treatment in vitro and in vivo. Molecular Cancer Therapeutics. PMID 36318650 DOI: 10.1158/1535-7163.MCT-21-0896 |
0.3 |
|
| 2022 |
Pribnow A, Jonchere B, Liu J, Smith KS, Campagne O, Xu K, Robinson S, Patel Y, Onar-Thomas A, Wu G, Stewart CF, Northcott PA, Yu J, Robinson GW, Roussel MF. Combination of ribociclib and gemcitabine for the treatment of medulloblastoma. Molecular Cancer Therapeutics. PMID 35709750 DOI: 10.1158/1535-7163.MCT-21-0598 |
0.304 |
|
| 2021 |
Liu J, You M, Yao Y, Ji C, Wang Z, Wang F, Wang D, Qi Z, Yu G, Sun Z, Guo W, Liu J, Li S, Jin Y, Zhao T, et al. SRSF1 plays a critical role in invariant natural killer T cell development and function. Cellular & Molecular Immunology. PMID 34522020 DOI: 10.1038/s41423-021-00766-w |
0.301 |
|
| 2021 |
Zhao S, Geng Y, Cao L, Yang Q, Pan T, Zhou D, Liu J, Shi Z, Zhang J. Deciphering the performance of polo-like kinase 1 in triple-negative breast cancer progression according to the centromere protein U-phosphorylation pathway. American Journal of Cancer Research. 11: 2142-2158. PMID 34094674 |
0.302 |
|
| 2020 |
Liu J, Liu X, Wu M, Qi G, Liu B. Engineering Living Mitochondria with AIE Photosensitizer for Synergistic Cancer Cell Ablation. Nano Letters. PMID 32969665 DOI: 10.1021/acs.nanolett.0c02778 |
0.305 |
|
| 2020 |
Li H, Liu Y, Liu X, Zhao D, Liu J, Cheng Y. A novel multi-target tyrosine kinase inhibitor anlotinib combined with irinotecan has in-vitro anti-tumor activity against human small-cell lung cancer. Anti-Cancer Drugs. PMID 32694423 DOI: 10.1097/CAD.0000000000000969 |
0.305 |
|
| 2020 |
Liu J, Luo X, Guo R, Jing W, Lu H. Cell metabolomics reveal berberine inhibited pancreatic cancer cell viability and metastasis by regulating citrate metabolism. Journal of Proteome Research. PMID 32692565 DOI: 10.1021/acs.jproteome.0c00394 |
0.307 |
|
| 2020 |
Cai FY, Yao XM, Jing M, Kong L, Liu JJ, Fu M, Liu XZ, Zhang L, He SY, Li XT, Ju RJ. Enhanced antitumor efficacy of functionalized doxorubicin plus schisandrin B co-delivery liposomes via inhibiting epithelial-mesenchymal transition. Journal of Liposome Research. 1-43. PMID 32200703 DOI: 10.1080/08982104.2020.1745831 |
0.301 |
|
| 2020 |
Yang J, Lian Y, Yang R, Lian Y, Wu J, Liu J, Wang K, Xu H. Upregulation of lncRNA LINC00460 Facilitates GC Progression through Epigenetically Silencing CCNG2 by EZH2/LSD1 and Indicates Poor Outcomes. Molecular Therapy. Nucleic Acids. 19: 1164-1175. PMID 32059342 DOI: 10.1016/j.omtn.2019.12.041 |
0.304 |
|
| 2019 |
Pan T, Zhou D, Shi Z, Qiu Y, Zhou G, Liu J, Yang Q, Cao L, Zhang J. Centromere Protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin-proteasomal degradation of COX-2. Cancer Letters. PMID 31705927 DOI: 10.1016/j.canlet.2019.11.003 |
0.305 |
|
| 2019 |
Hu M, Chen C, Liu J, Cai L, Shao J, Chen Z, Lin L, Zheng T, Ding X, Li Z. The melanogenic effects and underlying mechanism of paeoniflorin in human melanocytes and vitiligo mice. Fitoterapia. 104416. PMID 31704261 DOI: 10.1016/j.fitote.2019.104416 |
0.309 |
|
| 2018 |
Wang Y, Cui P, Liu J, Wu H, Ma J. Aclidinium bromide inhibits the growth and metastasis of gastric cancer MKN‑28 cells via the PI3K signaling pathway. Molecular Medicine Reports. PMID 29956761 DOI: 10.3892/mmr.2018.9220 |
0.308 |
|
| 2018 |
Cui Z, Li D, Liu J, Zhang Y, Xu H, Yin H, Li H, Wang G, Cai H, Zhang L, Duan S, Jiang H. G‑protein‑coupled receptor 120 regulates the development and progression of human esophageal cancer. Oncology Reports. PMID 29901155 DOI: 10.3892/or.2018.6470 |
0.312 |
|
| 2017 |
Liu J, He Y, Zhang D, Cai Y, Zhang C, Zhang P, Zhu H, Xu N, Liang S. In vitro anticancer effects of two novel phenanthroindolizidine alkaloid compounds on human colon and liver cancer cells. Molecular Medicine Reports. PMID 28677760 DOI: 10.3892/mmr.2017.6879 |
0.308 |
|
| 2016 |
Chen B, Zeng X, He Y, Wang X, Liang Z, Liu J, Zhang P, Zhu H, Xu N, Liang S. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways. Oncotarget. PMID 27662663 DOI: 10.18632/oncotarget.12147 |
0.302 |
|
| Show low-probability matches. |